Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Ketamine and Propofol NeuroImaging

NCT: NCT07294092 · RECRUITING

NCT IDNCT07294092
StatusRECRUITING
Start Date2026-04-10
Completion2028-08-02

Brief Summary

This is a multi-visit which will collect MRI (pictures of the brain) and EEG (brain waves) data to determine changes in brain connectivity and brain activity for memory formation and pain perception while receiving the commonly-used anesthetic agents ketamine and propofol, both alone and in combination.

Frequently Asked Questions

What is Ketamine and Propofol NeuroImaging?

Ketamine and Propofol NeuroImaging is a clinical trial registered under NCT07294092. Current status: RECRUITING.

What is the status of NCT07294092?

The current status of NCT07294092 (Ketamine and Propofol NeuroImaging) is: RECRUITING.

When did Ketamine and Propofol NeuroImaging start?

Ketamine and Propofol NeuroImaging started on 2026-04-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑